March/April 2005 Kaiser Health Poll Report – Toplines
Health News Index March/April, 2005 The March/April Kaiser Health Poll Report featured topic explores the public's views on the Medicare prescription drug benefit.
View the Latest: Prescription Drugs
Filter
-
-
Prescription Drug Coverage and Seniors: Findings from a 2003 National Survey
Other PostThis national survey of 17,685 seniors captures detailed information about their prescription drug use, coverage and experiences. It also includes state-specific comparative data for seniors in 12 states -- California, Colorado, Florida, Illinois, Louisiana, Michigan, New York, Ohio, Pennsylvania, Texas, Tennessee and Washington.
-
Low-Income Subsidies for the Medicare Prescription Drug Benefit: The Impact of the Asset Test
ReportThis study assesses the impact of the requirement that low-income people with Medicare meet an asset test in order to receive additional help paying premiums and cost-sharing under the new Medicare drug benefit. Report (.
-
One State’s Medicaid Managed Care Formulary Operations: A Look at Pennsylvania, 2001-2002
ReportOne State’s Medicaid Managed Care Formulary Operations: A Look at Pennsylvania, 2001-2002 This report examines formulary implementation under mandatory Medicaid managed care in Pennsylvania between 2001 and 2002. It looks at one state during a yearlong period; formulary operations are likely to vary across states and programs and over time.
-
Policy Workshop on Formularies and Medicare
Event Date:EventThe Kaiser Family Foundation hosted a March 14, 2005 policy workshop on the use of drug formularies in the private sector and their potential implications for beneficiaries under the new Medicare drug benefit, set to go into effect January 1, 2006.
-
The Effects of Formularies and Other Cost Management Tools on Access to Medications: An Analysis of the MMA and the Final Rule
Issue BriefThis report examines the formulary and cost management provisions of the final Medicare regulations implementing the new Medicare Part D drug benefit that was passed as part of the Medicare Modernization Act of 2003, and their implications for people with Medicare who enroll in new drug plans and their access to medications.
-
Cost Containment Strategies For Prescription Drugs: Assessing The Evidence In The Literature
ReportThis report describes and reviews various options to address prescription drug spending growth, including a description of each cost-containment strategy, its use by private or public payers, and a discussion of known evidence about its effectiveness or cost-saving potential.
-
Follow The Pill: Understanding the U.S. Commercial Pharmaceutical Supply Chain
ReportThe report describes the U.S. pharmaceutical supply chain, following prescription drugs as they move from manufacturers, to wholesale distributors, to pharmacies, and ultimately to patients. The report describes both the physical distribution of drugs through the chain, as well as the flow of money and the financial relationships among the key players.
-
A Comparison of Proposed and Final Regulations Governing Medicare Part D Plan Enrollment and Part D Benefit Appeal and Grievance Procedures
Issue BriefThis table highlights changes in the appeal and grievance procedures included in the proposed and final regulations implementing the drug benefit. It was prepared for the Foundation by Sara Rosenbaum, J.D., of the George Washington University School of Public Health. Issue Brief (.
-
Americans Value the Health Benefits of Prescription Drugs, But Say Drug makers Put Profits First, New Survey Shows – Toplines
Poll FindingThe most recent Kaiser Health Poll Report found that Americans believe prescription drugs are improving their lives, but most also say that the drug industry cares more about profits than people. The current report analyzes the new data as well as related polling information from earlier surveys by the Kaiser Family Foundation and other organizations.